IV Vancomycin

PreclinicalSmall molecule

MMelinta Therapeutics, Inc.

IV Vancomycin is one of 8 small molecule programs targeting Obese Patients. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Obese PatientsUnknown status

MethadoneCompleted

Obese PatientsPreclinical

Unknown status

MethadonePreclinical

Completed

Competition

Competitive Landscape

6 competitors in Obese Patients

#DrugCompanyPhaseTrials

Glucophage

EMD Serono

Approved

1 2

Zovirax

BBp Consulting, Inc

Phase 1

1 3

Esmeron

FFresenius Kabi USA, LLC

Preclinical

2 4

Blood Puncture Site

AAssistance Publique Hopitaux De Marseille

Preclinical

1 5

IV Vancomycin

MMelinta Therapeutics, Inc.

Preclinical

1 6

Anesthetics

MMedical University of Vienna

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Vancomycin3 trials

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

Completed·MMelinta Therapeutics, Inc.·Phase 3·NCT01252732·1,019 enrolled

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Completed·MMelinta Therapeutics, Inc.·Phase 3·NCT01252719·968 enrolled

Dose Escalation Trial of Intrasite Vancomycin Pharmacokinetics

Terminated·WWashington University School of Medicine·Phase 1·NCT01764750·10 enrolled

Obese Patients1 trial

Study of Obese Patients Comparing Two Vancomycin Loading Dose Regimens

Unknown status·—·N/A·NCT02764359·128 enrolled

Methadone1 trial

CYP2B6 Polymorphisms in Methadone Disposition

Completed·WWashington University School of Medicine·N/A·NCT01648283·78 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for IV Vancomycin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — IV Vancomycin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for IV Vancomycin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Melinta Therapeutics, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMelinta Therapeutics, Inc.

IV Vancomycin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Vancomycin3 trials

Obese Patients1 trial

Methadone1 trial

References

Drug Info

Quick Facts

Related News